The Emerging Role of Histotripsy in Liver Cancer Treatment: A Scoping Review

Abstract

Hepatocellular carcinoma (HCC) is an aggressive disease that can be resistant to conventional chemotherapy and radiotherapy. This scoping review explores how histotripsy can potentially be combined with immunotherapy to overcome refractory HCC. By delineating the limitations of current treatment strategies, we provide a comprehensive perspective on the advantages of histotripsy in the management of HCC and offer suggestions on how to maximize its clinical effectiveness.